Literature DB >> 21854278

Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies.

Jeffrey E Korte1, Kathryn M Magruder, Codruta C Chiuzan, Sarah L Logan, Therese Killeen, Dipankar Bandyopadhyay, Kathleen T Brady.   

Abstract

BACKGROUND: Selection of appropriate outcome measures is important for clinical studies of drug addiction treatment. Researchers use various methods for collecting drug use outcomes and must consider substances to be included in a urine drug screen (UDS); accuracy of self-report; use of various instruments and procedures for collecting self-reported drug use; and timing of outcome assessments.
OBJECTIVES: We sought to define a set of candidate measures to (1) assess their intercorrelation and (2) identify any differences in results.
METHODS: Data were combined from completed protocols in the National Institute on Drug Abuse Clinical Trials Network (CTN), with a total of 1897 participants. We defined nine outcome measures based on UDS, self-report, or a combination. Multivariable, multilevel generalized estimating equation models were used to assess subgroup differences in intervention success, controlling for baseline differences and accounting for clustering by CTN protocols.
RESULTS: There were high correlations among all candidate outcomes. All outcomes showed consistent overall results with no significant intervention impact on drug use during follow-up. However, with most UDS variables, but not with self-report or "corrected self-report," we observed a significant gender-ethnicity interaction with benefit shown in African American women, White women, and Hispanic men.
CONCLUSION: Despite strong associations between candidate measures, we found some important differences in results. SCIENTIFIC SIGNIFICANCE: In this study, we demonstrated the potential utility and impact of combining UDS and self-report data for drug use assessment. Our results suggest possible differences in intervention efficacy by gender and ethnicity, but highlight the need to cautiously interpret observed interactions.

Entities:  

Mesh:

Year:  2011        PMID: 21854278      PMCID: PMC3164549          DOI: 10.3109/00952990.2011.602997

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  11 in total

1.  Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Authors:  Daniel Falk; Xin Qun Wang; Lei Liu; Joanne Fertig; Margaret Mattson; Megan Ryan; Bankole Johnson; Robert Stout; Raye Z Litten
Journal:  Alcohol Clin Exp Res       Date:  2010-12       Impact factor: 3.455

2.  An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).

Authors:  Simon J Adamson; Frances J Kay-Lambkin; Amanda L Baker; Terry J Lewin; Louise Thornton; Brian J Kelly; J Douglas Sellman
Journal:  Drug Alcohol Depend       Date:  2010-03-26       Impact factor: 4.492

3.  The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.

Authors:  Eugene Somoza; Peggy Somoza; Daniel Lewis; Shou-Hua Li; Theresa Winhusen; Nora Chiang; Frank Vocci; Paul Horn; Ahmed Elkashef
Journal:  Drug Alcohol Depend       Date:  2007-10-29       Impact factor: 4.492

4.  Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test.

Authors:  Melissa M Howard; Robert M Weiler; J David Haddox
Journal:  J Sch Health       Date:  2009-11       Impact factor: 2.118

5.  Adaptation and validation of a self-report measure to evaluate substance use among Sri Lankan adolescents.

Authors:  A Chandrika Ismail; Rohini De Alwis Seneviratne
Journal:  Subst Use Misuse       Date:  2010       Impact factor: 2.164

6.  Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies.

Authors:  Megan S Schuler; William V Lechner; Rickey E Carter; Robert Malcolm
Journal:  J Addict Med       Date:  2009-12       Impact factor: 3.702

7.  Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report.

Authors:  Theresa M Winhusen; Eugene C Somoza; Bonita Singal; Sunme Kim; Paul S Horn; John Rotrosen
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

8.  Measuring outcome in interventions for alcohol dependence and problem drinking: executive summary of a conference sponsored by the national institute on alcohol abuse and alcoholism.

Authors:  John P Allen
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

Review 9.  Reduction in heavy drinking as a treatment outcome in alcohol dependence.

Authors:  David R Gastfriend; James C Garbutt; Helen M Pettinati; Robert F Forman
Journal:  J Subst Abuse Treat       Date:  2007-02-22

10.  Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial.

Authors:  Susan Tross; Aimee N C Campbell; Lisa R Cohen; Donald Calsyn; Martina Pavlicova; Gloria M Miele; Mei-Chen Hu; Louise Haynes; Nancy Nugent; Weijin Gan; Mary Hatch-Maillette; Raul Mandler; Paul McLaughlin; Nabila El-Bassel; Paul Crits-Christoph; Edward V Nunes
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

View more
  10 in total

Review 1.  A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?

Authors:  Breanne E Biondi; Xiaoying Zheng; Cynthia A Frank; Ismene Petrakis; Sandra A Springer
Journal:  Am J Addict       Date:  2020-04-29

2.  The design and analysis of multisite effectiveness trials: a decade of progress in the National Drug Abuse Clinical Trials Network.

Authors:  Edward V Nunes
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

3.  Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence.

Authors:  L Alba-Ferrara; F Fernandez; R Salas; G A de Erausquin
Journal:  Addict Disord Their Treat       Date:  2014-12

4.  A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  LaTrice Montgomery; Ann Kathleen Burlew; Angela M Haeny; Chizara A Jones
Journal:  Psychol Addict Behav       Date:  2019-06-27

5.  Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting.

Authors:  Lamia Y Haque; Jenna L Butner; Julia M Shi; Susan Henry; Yanhong Deng; Maria M Ciarleglio; Lynn M Madden; Jeanette M Tetrault
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

Review 6.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

7.  The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.

Authors:  Dikla Shmueli-Blumberg; Lian Hu; Colleen Allen; Michael Frasketi; Li-Tzy Wu; Paul Vanveldhuisen
Journal:  Clin Trials       Date:  2013-10-01       Impact factor: 2.486

8.  The Use of Neuromodulation in the Treatment of Cocaine Dependence.

Authors:  Lucia M Alba-Ferrara; Francisco Fernandez; Gabriel A de Erausquin
Journal:  Addict Disord Their Treat       Date:  2014-03-01

9.  Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis.

Authors:  Meredith K Ginley; Rory A Pfund; Carla J Rash; Kristyn Zajac
Journal:  J Consult Clin Psychol       Date:  2021-01

Review 10.  Hispanic participants in the National Institute on Drug Abuse's Clinical Trials Network: A scoping review of two decades of research.

Authors:  Brittany H Eghaneyan; Katherine Sanchez; Angela M Haeny; LaTrice Montgomery; Teresa Lopez-Castro; A Kathleen Burlew; Afsaneh Rezaeizadeh; Michael O Killian
Journal:  Addict Behav Rep       Date:  2020-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.